In context
Dipeptide diaminobutyroyl benzylamide diacetate has been evaluated as one ingredient in a multi-ingredient topical serum, with ex-vivo skin work and two human cosmetic studies. [1]
At a glance
- Type
- Topical cosmetic ingredient
- Regulatory context
- The cited source describes research, not a determination of present marketing authorisation. Country, formulation and indication must be checked separately.
- Evidence
- The serum also contained other active ingredients. Its findings cannot isolate the contribution of this ingredient or support injected use.
How to interpret this evidence
The serum also contained other active ingredients. Its findings cannot isolate the contribution of this ingredient or support injected use. [1]
Safety and clinical context
Topical cosmetic research does not support injection or other systemic use. Safety and tolerability depend on the complete formulation and the person using it.
Evidence and authorisation depend on the product, formulation, indication and country. US labelling does not establish Thai authorisation. This guide is educational and is not a dosing or self-treatment protocol.
Primary sources
Read the underlying source and its limitations. A study citation does not by itself establish efficacy or approval.